Objectives
After participating in this educational activity, attendees should be able to:
1| Describe the Pathophysiology and diagnosis of cystic fibrosis
2| Summarize the management of respiratory disease, the role of modulators, and new frontiers in the treatment of people with cystic fibrosis.
3| Distinguish unique challenges in caring for people with cystic fibrosis in a primary care setting.
Presenter(s):
Thomas Presti, MD
Associate Medical Director, Cystic Fibrosis Care Center
Associate Program Director, Pulmonary and Critical Care Fellowship
Division of Pulmonary & Critical Care Medicine
UMass Chan Medical School-Baystate
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
Thomas Presti, MD | Speaker | No relevant relationships with ineligible companies to disclose | elexacaftor/tezacaftor/ivacaftor azithromycin |
Session date:
04/01/2026 - 8:00am to 9:00am EDT
Location:
Baystate Medical Center & Webinar
759 Chestnut Street
Springfield, MA
01199
United States
See map: Google Maps
Add to calendar:
- 1.00 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 1.00 ACPE Contact Hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 IPCE Credit Hour(s)
Facebook
X
LinkedIn
Forward